Medicare Enrolled

Dr. Arnie Tannenbaum, MD

Urology Physician · Hudson, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7614 JACQUE RD, Hudson, FL 34667
7278628548
In practice since 2006 (19 years)
NPI: 1952348971 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tannenbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tannenbaum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tannenbaum

Dr. Arnie Tannenbaum is an urology physician in Hudson, FL, with 19 years in practice. Based on federal Medicare data, Dr. Tannenbaum performed 6,573 Medicare services across 3,457 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tannenbaum received a total of $1,289 from 25 pharmaceutical and/or device companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tannenbaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 19% volume in FL$ $1,289 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,573
Medicare services
Top 19% in FL for urology physician
3,457
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~346 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
BCG treatment for bladder cancer1,700$2$8
Automated urinalysis1,015$2$11
Office visit, established patient (20-29 min)938$65$263
Bladder ultrasound after voiding668$8$32
Office visit, established patient (30-39 min)534$87$376
Blood draw (venipuncture)164$8$25
PSA test (prostate cancer screening)154$18$68
Diagnostic exam of bladder and urethra using an endoscope148$181$692
Leuprolide acetate (for depot suspension), 7.5 mg141$133$534
New patient office visit (45-59 min)108$116$492
Injection, tobramycin sulfate, up to 80 mg105$2$8
Infusion, normal saline solution, 250 cc93$0$2
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional84$16$67
Initial hospital admission, moderate complexity77$102$406
Hospital follow-up visit, moderate complexity73$63$210
Simple bladder irrigation and/or instillation65$55$226
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle52$26$97
Instillation of anti-cancer drug into bladder49$68$261
Simple insertion of temporary bladder tube43$48$179
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant38$40$3,202
Insertion of lower leg neurostimulator electrode38$83$342
New patient office visit (30-44 min)29$77$323
Electronic assessment of bladder emptying25$7$46
Office visit, established patient (10-19 min)24$40$161
Insertion of temporary bladder tube23$35$131
Insertion of stent in ureter using an endoscope18$104$1,270
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings17$28$241
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies15$297$547
Insertion of device into abdomen with pressure and urine flow rate study15$147$552
Biopsy of prostate gland15$103$720
Office visit, established patient, complex (40-54 min)15$83$525
Exam with injections of chemical for destruction of bladder using an endoscope14$79$1,154
New patient office visit, complex (60-74 min)14$142$651
Initial hospital admission, high complexity14$133$521
Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope12$117$2,195
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant12$160$4,005
Ultrasound scan of pelvic region through rectum12$25$583
Urinalysis, manual12$3$12
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
13.2% medium
85.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,289
Total received (2018-2024)
Avg $184/year across 7 years
Bottom 28% in FL for urology physician
25
Companies
65
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,237 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$142
2023
$491
2022
$274
2021
$128
2020
$65
2019
$103
2018
$86

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$260
Astellas Pharma US Inc
$202
Janssen Biotech, Inc.
$191
Teleflex LLC
$97
PROCEPT BioRobotics Corporation
$60
TOLMAR Pharmaceuticals, Inc.
$55
COLOPLAST CORP
$49
Endo Pharmaceuticals Inc.
$41
Telix Pharmaceuticals
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
Avadel Specialty Pharmaceuticals, LLC
$28
AbbVie Inc.
$25
UROGEN PHARMA, INC.
$24
Olympus America Inc.
$22
Merck Sharp & Dohme LLC
$20
Sumitomo Pharma America, Inc.
$20
Myovant Sciences Inc.
$19
UROVANT SCIENCES INC
$19
Myriad Genetic Laboratories, Inc.
$19
Medtronic, Inc.
$15
Ferring Pharmaceuticals Inc.
$15
ACCORD HEALTHCARE, INC.
$14
Allergan Inc.
$13
UroGen Pharma, Inc.
$13
NeoTract Inc.
$12
Top 3 companies account for 50.6% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · GEMTESA · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · MYRBETRIQ · Noctiva · Nubeqa · ORGOVYX · Prolaris · Titan · UROLIFT · UroLift · XIAFLEX · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $20 per 100 Medicare services performed
Looking for a urology physician in Hudson?
Compare urology physicians in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
28
Per 100K population
4.8
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tannenbaum is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tannenbaum experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Tannenbaum performed 1,700 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tannenbaum receive payments from pharmaceutical companies?
Yes. Dr. Tannenbaum received a total of $1,289 from 25 companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tannenbaum's costs compare to other urology physicians in Hudson?
Dr. Tannenbaum's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tannenbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →